NO20052751D0 - Oftalmisk preparat for behandling av okulaer hypertensjon. - Google Patents

Oftalmisk preparat for behandling av okulaer hypertensjon.

Info

Publication number
NO20052751D0
NO20052751D0 NO20052751A NO20052751A NO20052751D0 NO 20052751 D0 NO20052751 D0 NO 20052751D0 NO 20052751 A NO20052751 A NO 20052751A NO 20052751 A NO20052751 A NO 20052751A NO 20052751 D0 NO20052751 D0 NO 20052751D0
Authority
NO
Norway
Prior art keywords
treatment
ocular hypertension
ophthalmic preparation
ophthalmic
preparation
Prior art date
Application number
NO20052751A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052751L (no
Inventor
James B Doherty
Meng-Hsin Chen
Luping Liu
Swaminathan R Natarajan
Robert M Tynebor
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO20052751D0 publication Critical patent/NO20052751D0/no
Publication of NO20052751L publication Critical patent/NO20052751L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C07F9/65038—Five-membered rings having the nitrogen atoms in the positions 1 and 2 condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20052751A 2002-11-08 2005-06-07 Oftalmisk preparat for behandling av okulaer hypertensjon. NO20052751L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42480802P 2002-11-08 2002-11-08
US50009103P 2003-09-04 2003-09-04
PCT/US2003/035080 WO2004043933A1 (en) 2002-11-08 2003-11-04 Ophthalmic compositions for treating ocular hypertension

Publications (2)

Publication Number Publication Date
NO20052751D0 true NO20052751D0 (no) 2005-06-07
NO20052751L NO20052751L (no) 2005-06-07

Family

ID=32314559

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052751A NO20052751L (no) 2002-11-08 2005-06-07 Oftalmisk preparat for behandling av okulaer hypertensjon.

Country Status (22)

Country Link
US (2) US7196082B2 (ru)
EP (1) EP1562909B1 (ru)
JP (2) JP4456072B2 (ru)
KR (1) KR20050072805A (ru)
AR (1) AR041991A1 (ru)
AU (2) AU2003287506B8 (ru)
BR (1) BR0316040A (ru)
CA (1) CA2505086C (ru)
CL (1) CL2003002293A1 (ru)
DO (1) DOP2003000747A (ru)
EC (1) ECSP055781A (ru)
HR (1) HRP20050409A2 (ru)
IS (1) IS7822A (ru)
MA (1) MA27497A1 (ru)
MX (1) MXPA05004889A (ru)
NO (1) NO20052751L (ru)
NZ (1) NZ539593A (ru)
PE (1) PE20040692A1 (ru)
PL (1) PL377172A1 (ru)
RU (1) RU2005117627A (ru)
TW (1) TWI250873B (ru)
WO (2) WO2004043932A1 (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040028469A (ko) 2002-09-30 2004-04-03 엘지전자 주식회사 1 회 기록 가능한 광디스크의 디펙트 영역 관리방법
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
KR20060090801A (ko) * 2003-09-04 2006-08-16 머크 앤드 캄파니 인코포레이티드 고안압증 치료용 안용 조성물
CN1988903A (zh) * 2004-07-20 2007-06-27 默克公司 用于治疗高眼压症的眼用组合物
EP1647549A1 (en) 2004-10-14 2006-04-19 Laboratoire Theramex Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents
CN101415685B (zh) * 2006-01-31 2011-08-24 阿雷生物药品公司 激酶抑制剂及其使用方法
AU2007227664A1 (en) * 2006-03-13 2007-09-27 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
US8008481B2 (en) * 2006-03-31 2011-08-30 Ericsson Anna M Indazole compounds
US20100113472A1 (en) * 2008-11-03 2010-05-06 Chemocentryx, Inc. Compounds for the treatment of osteoporosis and cancers
US8980924B2 (en) 2010-11-24 2015-03-17 The Trustees Of Columbia University In The City Of New York Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease
WO2013166037A1 (en) 2012-05-01 2013-11-07 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of eye disorders
WO2014151959A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
WO2014151936A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles, their preparation and use
DK2968304T3 (en) 2013-03-14 2019-01-28 Univ Columbia 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE.
EP2968303B1 (en) 2013-03-14 2018-07-04 The Trustees of Columbia University in the City of New York Octahydrocyclopentapyrroles, their preparation and use
EP4036094A1 (en) 2014-04-30 2022-08-03 The Trustees of Columbia University in the City of New York Substituted 4-phenylpiperidines, their preparation and use
CN104211638A (zh) * 2014-08-13 2014-12-17 李增 一种脂肪氨基取代的芸香碱类衍生物及其制备和作为抗阿尔兹海默症的药物中的应用
US20190016680A1 (en) 2016-01-14 2019-01-17 Beth Israel Deaconess Medical Center, Inc. Mast-cell modulators and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534580A1 (fr) 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
US5151444B1 (en) 1987-09-18 1999-07-06 R Tech Ueno Ltd Ocular hypotensive agents
WO1989010757A1 (en) 1988-05-10 1989-11-16 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemis New ophthalmic preparation for treating glaucoma
DE03014533T1 (de) 1988-09-06 2004-07-15 Pharmacia Ab Prostaglandinderivative zur Behandlung von Glaukom oder okuläre Hypertension
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5352708A (en) 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5922773A (en) 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
FR2701026B1 (fr) 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
JP3208210B2 (ja) * 1993-03-17 2001-09-10 旭化成株式会社 結晶性芳香族ポリカーボネートプレポリマーの製造方法及び芳香族ポリカーボネートの製造方法
EP0724443A4 (en) 1993-06-08 1997-09-10 Vide Pharmaceuticals METHOD AND PREPARATIONS FOR LOWERING THE EYE PRESSURE
US5510383A (en) 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5573758A (en) 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
AP2001002304A0 (en) * 1996-05-03 2001-12-31 Pfizer Substituted indazole derivatives and related compounds
US5925342A (en) 1996-11-13 1999-07-20 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
US6586468B1 (en) 1998-09-14 2003-07-01 Ono Pharmaceutical Co., Ltd. ω-substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient
AP2001002357A0 (en) 1999-12-22 2001-12-31 Pfizer Prod Inc EP4 receptor selective agonists in the treatment of osteoporosis.
WO2001052876A1 (en) 2000-01-18 2001-07-26 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
CA2402403A1 (en) 2000-03-17 2001-09-27 Alcon, Inc. 6-hydroxy-indazole derivatives for treating glaucoma
US6956036B1 (en) * 2000-03-17 2005-10-18 Alcon, Inc. 6-hydroxy-indazole derivatives for treating glaucoma
EP1268439A1 (en) 2000-03-17 2003-01-02 Alcon Inc. 5-hydroxy indazole derivatives for treating glaucoma
CN1366458A (zh) 2000-03-31 2002-08-28 东丽株式会社 毛发生长和毛发形成调节剂
WO2002024647A1 (fr) 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
PT1339678E (pt) 2000-11-27 2007-11-30 Pfizer Prod Inc Agonistas selectivos do receptor ep4 no tratamento de osteoporose
FR2827861B1 (fr) 2001-07-27 2004-04-02 Aventis Pharma Sa Derives des indazoles ou des indoles, leur utilisation en medecine humaine et plus particulierement en cancerologie

Also Published As

Publication number Publication date
RU2005117627A (ru) 2006-01-20
BR0316040A (pt) 2005-09-13
US20070129418A1 (en) 2007-06-07
KR20050072805A (ko) 2005-07-12
US20040097575A1 (en) 2004-05-20
AU2003287506B2 (en) 2009-04-23
HRP20050409A2 (en) 2006-02-28
EP1562909A1 (en) 2005-08-17
ECSP055781A (es) 2005-09-20
NZ539593A (en) 2006-12-22
MA27497A1 (fr) 2005-08-01
TW200501949A (en) 2005-01-16
JP2006508190A (ja) 2006-03-09
AR041991A1 (es) 2005-06-08
US7547720B2 (en) 2009-06-16
MXPA05004889A (es) 2005-07-22
TWI250873B (en) 2006-03-11
JP4456072B2 (ja) 2010-04-28
DOP2003000747A (es) 2004-05-31
JP2010006825A (ja) 2010-01-14
NO20052751L (no) 2005-06-07
AU2003286884A1 (en) 2004-06-03
PL377172A1 (pl) 2006-01-23
US7196082B2 (en) 2007-03-27
WO2004043932A1 (en) 2004-05-27
PE20040692A1 (es) 2004-10-08
CL2003002293A1 (es) 2005-01-14
AU2003287506A1 (en) 2004-06-03
IS7822A (is) 2005-04-25
WO2004043933A1 (en) 2004-05-27
CA2505086C (en) 2009-08-25
EP1562909B1 (en) 2012-06-27
JP5061293B2 (ja) 2012-10-31
AU2003287506B8 (en) 2009-05-28
CA2505086A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
NO20052751D0 (no) Oftalmisk preparat for behandling av okulaer hypertensjon.
DK1509121T3 (da) Okulærvisningsapparat til behandling af øjenlidelser
IL176393A (en) Patterned laser treatment of the retina
CY2015025I2 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
DK1656346T3 (da) 1,2,3,4-tetrasubstituerede indol til behandling af luftvejssygdomme
NO20053041D0 (no) Behandling av diabetes.
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
AP2005003283A0 (en) Indole derivatives useful for the treatment os diseases
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DE60325209D1 (de) Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen
EP1732484A4 (en) OPHTHALMIC IMPLANT FOR THE TREATMENT OF GLAUCOMA
NO20034590D0 (no) Fremgangsmåter for behandling av vaskul¶r sykdom
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
NO20053211D0 (no) Forbindelser for behandling av metabolske forstyrrelser.
FR2841767B1 (fr) Lentille intraoculaire accommodative
GB2402674B (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
EP1581503A4 (en) OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
EP1515721A4 (en) OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom